ArticlePeerJ. Computer science2024
Enabling blockchain for Saudi Arabia drug supply chain using Internet of Things (IoT).
Article in PeerJ. Computer science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- BHFVAL: Block chain-Enabled Hierarchical Federated Variational Auto encoder Framework for Secure Intrusion Detection in Vehicular Networks.Scientific reports · 2025Article
- Developing real-time IoT-based public safety alert and emergency response systems.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The availability of drugs across the country is a direct measure for fairer public health. Several issues have been reported drastically related to various organizations that fail to provide quality medicines on time. There has been a consistent increase in cases where the treatment, as well as exempted drugs, were supplied due to the unavailability of proper traceability of the supply chain. Several parties are involved in the supply and have similar interests that may defer the adequate shareability of the drugs. The existing system for managing the drug supply chain suffers from several backlogs. The loss of information, unavailability of resources to track the proper medicinal storage, transparency of information sharing between various stakeholders and sequential access. The applicability of the decentralized model emerging from the blockchain can apply to one of the perfect solutions in this case. The drug traceability chain can be deployed to a Ledger-based blockchain that may result in decentralized information. Continuous supply from the Internet of Things (IoT) based devices might be handy as the middleware for providing a trustworthy, safe, and proper transaction-oriented system. The data integrity, along with the provenance resulting from the IoT-connected devices, is an effective solution towards managing the supply chain and drug traceability. This study presents a model that can provide a token-based blockchain that will help provide a cost-efficient and secure system for a reliable drug supply chain.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.